When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HGEN - Humanigen expands lenzilumab partnership with Catalent
Humanigen Inc.
Humanigen (OTCQB:HGEN)expands its partnership with Catalent (NYSE:CTLT) under which the latter will provide development, manufacturing and commercialization services for lenzilumab, Humanigen’s proprietary Humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody.
More news on: Humanigen, Inc., Catalent, Inc., Healthcare stocks news,